Tandem Diabetes Care (TNDM) Long-Term Investments (2014 - 2026)

Tandem Diabetes Care's Long-Term Investments history runs 6 years deep, the most recent figure standing at $56.5 million for Q1 2026.

• Quarterly Long-Term Investments fell 20.45% year-over-year to $56.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $56.5 million (down 20.45% YoY) and the FY2025 annual result came in at $60.4 million, down 18.93% from the prior year.
• Long-Term Investments was $56.5 million for Q1 2026 at Tandem Diabetes Care, down from $60.4 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $74.5 million in Q4 2024 and bottomed at $56.5 million in Q1 2026.
• A 3-year average of $65.8 million and a median of $66.3 million in 2025 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2025 — Long-Term Investments slipped 18.93% — and 2026, when it retreated 20.45%.
• Tandem Diabetes Care's Long-Term Investments stood at $74.5 million in 2024, then decreased by 18.93% to $60.4 million in 2025, then slipped by 6.48% to $56.5 million in 2026.
• Business Quant data shows TNDM's Long-Term Investments at $56.5 million in Q1 2026, $60.4 million in Q4 2025, and $64.9 million in Q3 2025.